Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.The company's therapies deliver nucleic acids and other molecules to skeletal, cardiac and smooth muscle with unprecedented precision, enabling patients to restore muscle strength and transform their lives.
View Top Employees for Dyne Therapeutics
|
Website | dyne-tx.com |
|
Industry | Biotechnology |
|
Location | Waltham, Massachusetts, United States |
|
Employees | 40 |
|
Founded | 2018 |
|
HQ | 400 Technology Square 10th Floor |
|
Funding | 333,000,000 USD |
|
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
|
|
Website | dyne-tx.com |
|
|
Industry | Biotechnology |
|
|
Location | Waltham, Massachusetts, United States |
|
|
Employees | 40 |
|
|
Founded | 2018 |
|
linkedin.com/company/dynetx | |
|
|
HQ | 400 Technology Square 10th Floor |
|
|
Funding | 333,000,000 USD |
Email Patterns for Dyne Therapeutics
Top Competitors for Dyne Therapeutics
Dyne Therapeutics Questions
Where are Dyne Therapeutics's headquarters?
Dyne Therapeutics's headquarters are in 400 Technology Square 10th Floor
What is Dyne Therapeutics's official website?
Dyne Therapeutics's website is dyne-tx.com
How many employees are working in Dyne Therapeutics right now?
Dyne Therapeutics has
40 employees.
View the Email and Phone Numbers for all 40 working at Dyne Therapeutics.
What is Dyne Therapeutics's industry?
Dyne Therapeutics's industry is
Biotechnology
Who are Dyne Therapeutics's top competitors?
Dyne Therapeutics's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What are Dyne Therapeutics's categories?
Dyne Therapeutics's categories are Biotechnology, Health Care, Medical, Pharmaceutical
What is Dyne Therapeutics's location?
Dyne Therapeutics's location is
Waltham, Massachusetts, United States
When was Dyne Therapeutics's founded?
Dyne Therapeutics's founding year is 2018
What is Dyne Therapeutics's funding?
Dyne Therapeutics's funding is 333,000,000 USD
What is Dyne Therapeutics's current status?
Dyne Therapeutics's current status is ipo
Top Dyne Therapeutics Employees
Senior Manager Supply Chain Management
jamandblue311@yahoo.com
+1978-837-2095
President And Chief Executive Officer
jbrumm@versartis.com
+1650-963-8580
Vice President, Corporate Communications And Investor Relations
amy.reilly@biogenidec.com
+1207-363-7121
Scientist
waybio@yahoo.com
+1480-239-3621
Senior Manager Of External Reporting And Technical Accounting
+1610-202-9973
Vice President, Program Team Leader
tsengupta@alnylam.com
+1763-542-0800
Vice President, Program Team Leader And Head Of New Product Planning
bnewkirk@alnylam.com
+1617-407-4936
